Published in Lancet on January 28, 1989
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Sarkosyl activation of RNA polymerase activity in mitotic mouse cells. FEBS Lett (1974) 2.74
Isolation of a polyoma-nucleoprotein complex from infected mouse-cell cultures. Proc Natl Acad Sci U S A (1971) 2.64
Transport and storage of vitamin A. Science (1990) 2.39
Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) (2008) 2.15
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res (1993) 1.98
Effect of a recA gene on cell division and capsular polysaccharide production in a lon strain of Escherichia coli. Genet Res (1969) 1.64
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience (1989) 1.64
The dysplastic nevus syndrome: our definition. Am J Dermatopathol (1982) 1.63
Isolation of two forms of SV40 nucleoprotein containing RNA polymerase from infected monkey cells. Virology (1976) 1.63
Vitamin A metabolism: new perspectives on absorption, transport, and storage. Physiol Rev (1991) 1.59
Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet (1991) 1.59
The inpatient neurology consultation service: value and cost. Clin Med (2011) 1.56
Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease. Lancet (1999) 1.52
Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int J Radiat Biol (1988) 1.50
Inactivation of the prophage lambda repressor without induction. J Mol Biol (1966) 1.49
Recently replicated simian virus 40 DNA is a preferential template for transcription and replication. J Virol (1978) 1.48
Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin Pharmacol Ther (1975) 1.46
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat Res (1988) 1.38
Properties of the polyoma virus transcription complex obtained from mouse nuclei. Virology (1974) 1.37
Genetics of nitrofurazone resistance in Escherichia coli. J Bacteriol (1978) 1.32
Repair-deficient bacterial strains suitable for mutagenicity screening: tests with the fungicide captain. Chem Biol Interact (1972) 1.30
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology (1989) 1.29
Mutagen testing using TRP+ reversion in Escherichia coli. Mutat Res (1976) 1.27
exrB: a malB-linked gene in Escherichia coli B involved in sensitivity to radiation and filament formation. Genet Res (1974) 1.26
Genetic analysis of sul mutants of Escherichia coli B. Genet Res (1971) 1.24
Conditional induction of lambda-prophage in exrA mutants of Escherichia coli. Genet Res (1971) 1.21
Biosynthetic properties of a polyoma nucleoprotein complex: evidence for replication sites. J Virol (1972) 1.21
A comparison of physiotherapy techniques for patients with Parkinson's disease. Cochrane Database Syst Rev (2001) 1.21
Studies on the control of ribosomal RNA synthesis in HeLa cells. Eur J Biochem (1975) 1.20
Benefit from adrenocorticotrophin in myasthenia gravis. J Neurol Neurosurg Psychiatry (1974) 1.17
Interaction of the exr and lon genes in Escherichia coli. J Bacteriol (1968) 1.15
Use of a simplified fluctuation test to detect low levels of mutagens. Mutat Res (1976) 1.14
The sv40 transcription complex. I. Effect of viral chromatin proteins on endogenous RNA polymerase activity. Nucleic Acids Res (1977) 1.12
Effect of the lambda repressor on the binding of RNA polymerase to DNA. Proc Natl Acad Sci U S A (1969) 1.10
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol (2005) 1.09
Cerebral localisation in articulatory dyspraxia. J Neurol Neurosurg Psychiatry (1992) 1.07
Characterization of the intrinsic properties of the anterior cruciate and medial collateral ligament cells: an in vitro cell culture study. J Orthop Res (1992) 1.07
A multicompartmental model of vitamin A kinetics in rats with marginal liver vitamin A stores. J Lipid Res (1985) 1.05
Repression of induction by U.V. of lambda phage by exrA mutations in Escherichia coli. Genet Res (1970) 1.04
UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome. EMBO J (2000) 1.04
Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol (1996) 1.04
Factors affecting the DNA damaging activity of superoxide and nitric oxide. Mutat Res (1998) 1.01
The sv40 transcription complex. II. Non-dissociation of protein from SV40 chromatin during transcription. Nucleic Acids Res (1977) 1.01
Inhibition of DNA replication by ionizing radiation is mediated by a trans-acting factor. Int J Radiat Biol (1989) 1.00
A comparison of the response of unstimulated and stimulated T-lymphocytes and fibroblasts from normal, xeroderma pigmentosum and trichothiodystrophy donors to the lethal action of UV-C. Mutat Res (1992) 0.99
Physiotherapy for patients with Parkinson's Disease: a comparison of techniques. Cochrane Database Syst Rev (2001) 0.99
Kinetic analysis shows that iron deficiency decreases liver vitamin A mobilization in rats. J Nutr (2000) 0.99
Amantadine for dyskinesia in Parkinson's disease. Cochrane Database Syst Rev (2003) 0.98
Second European workshop on bacterial in vitro mutagenicity test systems (Ames test meeting 1979). Mutat Res (1980) 0.98
The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect. Cancer Res (2000) 0.98
Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet (1993) 0.98
DNA strand breakage caused by dichlorvos, methyl methanesulphonate and iodoacetamide in Escherichia coli and cultured Chinese hamster cells. Mutat Res (1974) 0.97
The fluctuation test as a more sensitive system for determining induced mutation in L5178Y mouse lymphoma cells. Mutat Res (1976) 0.96
Treatment of polyneuropathy with azathioprine. Lancet (1970) 0.95
Regulation of bacteriophage lambda DNA replication. Proc Natl Acad Sci U S A (1967) 0.95
Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutat Res (1992) 0.95
Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide. Br J Pharmacol (2007) 0.95
Inhibition of Escherichia coli and bacteriophage lambda messenger RNA synthesis by T4. Proc Natl Acad Sci U S A (1965) 0.95
Icarus's syndrome: new hazards in flight. Br Med J (1977) 0.95
Variation in retinol utilization rate with vitamin A status in the rat. J Nutr (1987) 0.93
An immediate effect of inhibition of DNA synthesis on cell division in a Lon strain of Escherichia coli. Mutat Res (1970) 0.93
Endogenous nitric oxide induced by interleukin-1 beta in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett (1993) 0.92
Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain (1999) 0.92
Sensitivity of PCR in detecting monoclonal B cell proliferations. J Clin Pathol (1993) 0.92
Positive immunoglobulin gene rearrangement study by the polymerase chain reaction in a colonic adenocarcinoma. Am J Clin Pathol (1992) 0.92
Deficiencies in anti-acetylcholine receptor antibody measurement in myasthenia gravis. J Neurol Neurosurg Psychiatry (1991) 0.92
Vitamin A: physiological and biochemical processing. Annu Rev Nutr (1992) 0.92
Ventriculoperitoneal shunt procedure complicated by ureter obstruction. Case report. J Neurosurg (1983) 0.91
Plasma retinol is a major determinant of vitamin A utilization in rats. J Nutr (1998) 0.91
A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine. Br J Clin Pract (1972) 0.91
Surgery for Parkinson's disease: lack of reliable clinical trial evidence. J Neurol Neurosurg Psychiatry (2003) 0.91
CD40 ligation for immunotherapy of solid tumours. J Immunol Methods (2001) 0.90
Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol (2009) 0.90
A derivative of an ataxia-telangiectasia (A-T) cell line with normal radiosensitivity but A-T-like inhibition of DNA synthesis. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.90
Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group. Hosp Med (1998) 0.90
Induction of cyclobutane pyrimidine dimers, pyrimidine(6-4)pyrimidone photoproducts, and Dewar valence isomers by natural sunlight in normal human mononuclear cells. Cancer Res (1995) 0.90
Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis (1990) 0.90
Acute polyneuropathy complicating chronic renal failure. Nephron (1971) 0.89
Mutagenic DNA repair in Escherichia coli. II. Factors affecting loss of photoreversibility of UV induced mutations. Mol Gen Genet (1975) 0.89
Clinical spectrum of neuroleptic malignant syndrome. Lancet (1988) 0.89
Retinol metabolism in rats with low vitamin A status: a compartmental model. J Lipid Res (1990) 0.89
Spontaneous and ultraviolet-induced mutation in Escherichia coli: interaction between plasmid and tif-i mutator effects. J Gen Microbiol (1977) 0.89
Apoptosis and cytokine release induced by ionizing or ultraviolet B radiation in primary and immortalized human keratinocytes. Carcinogenesis (2000) 0.89
Early-late transcription switch: isolation of a lambda DNA-RNA polymerase complex active in the synthesis of late RNA. Biochem Biophys Res Commun (1968) 0.89
An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. Mutat Res (1994) 0.88
Plasma thyroid hormone kinetics are altered in iron-deficient rats. J Nutr (1998) 0.88
Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric Oxide (1998) 0.88
Mutation to prototrophy in Escherichia coli K-12: effect of broth on UV-induced mutation in strain AB1157 and four excision-deficient mutants. Mutat Res (1972) 0.88
Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry (1995) 0.88
Mutagenicity of dichlorvos and methyl methanesulphonate for Escherichia coli WP2 and some derivatives deficient in DNA repair. Mutat Res (1973) 0.88
Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats. Am J Clin Nutr (1986) 0.87
Non-pharmacological therapies for dysphagia in Parkinson's disease. Cochrane Database Syst Rev (2001) 0.87